ELECTROENCEPHALOGRAPHIC CHANGES AND PROGNOSIS FOR THE DEVELOPMENT OF EPILEPSY IN PATIENTS WITH POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES): LITERATURE REVIEW
https://doi.org/10.17650/2073-8803-2017-12-2-43-51
Abstract
Posterior reversible encephalopathy syndrome (PRES) is an acute and usually reversible condition characterized by a rapid onset, convulsive syndrome, impaired consciousness, headache, visual impairment, nausea or vomiting, transient focal neurological signs, and arterial hypertension. Patients with PRES have changes in the white matter of the brain detected using magnetic resonance imaging; these changes are predominantly located in the occipital-temporal-parietal area. Increased blood pressure and severe metabolic disorders are the risk factors for PRES. Most of the patients have generalized tonic-clonic or focal seizures and epileptiform activity on the electroencephalogram during the acute period of PRES, but they do not develop epilepsy after this episode.
About the Authors
M. Yu. Bobylova
Svt. Luka’s Institute of Child and Adult Neurology and Epilepsy
Russian Federation
9 Akademika Anokhina Str., Moscow 119579
Russian Federation
9 Akademika Anokhina Str., Moscow 119579
A. Yu. Zakharova
D. Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology
Russian Federation
1 Samory Mashela Str., 117997
Russian Federation
1 Samory Mashela Str., 117997
S. P. Khomyakova
D. Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology
Russian Federation
1 Samory Mashela Str., 117997
Russian Federation
1 Samory Mashela Str., 117997
References
1. Добрынина Л.А., Калашникова Л.А., Бакулин И.С. и др. Синдром задней обратимой энцефалопатии при гипокальциемии: описание наблюдения и анализ патогенетической значимости электролитных нарушений. Журнал неврологии и психиатрии им. С.С. Корсакова 2016;116(7):70–7. [Dobrynina L.A., Kalashnikova L.A., Bakulin I.S. et al. Posterior reversible encephalopathy syndrome in patients with hypocalcemia: a case report and the analysis of electrolyte imbalance significance. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry 2016;116(7):70–7. (In Russ.)].
2. Пизова Н.В. Синдромобратимой задней лейкоэнцефалопатии при системной красной волчанке. Неврологический журнал 2014;19(6):44–9. [Pizova N.V. Reversible posterior leukoencephalopathy syndrome in patients with systemic lupus erythematosus. Nevrologicheskiy zhurnal = Neurological Journal 2014;19(6):44–9. (In Russ.)].
3. СкворцоваВ.И., ГубскийЛ.В., МельниковаЕ.А. Синдромзадней обратимой энцефалопатии. Журнал неврологии и психиатрии им. С.С. Корсакова 2010;110(5):104–9. [Skvortsova V.I., Gubskiy L.V., Melnikova E.A. Posterior reversible encephalopathy syndrome. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry 2010;110(5):104–9. (In Russ.)].
4. Bartynski W.S., Boardman J.F. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 2007;28(7):1320–7. DOI: 10.3174/ajnr.A0549.
5. Bartynski W.S. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol 2008;29(6):1036–42. DOI: 10.3174/ajnr.A0928.
6. Bartynski W.S. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 2008;29(6):1043–9. DOI: 10.3174/ajnr.A0929.
7. Burnett M.M., Hess C.P., Roberts J.P. et al. Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors. Clin Neurol Neurosurg 2010;112(10):886–9. DOI: 10.1016/j.clineuro.2010.07.023.
8. Casey S.O., Sampaio R.C., Michel E. et al. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 2000;21(7):1199–1206. PMID: 10954269.
9. Cherian A., Soumya C.V., Iype T. et al. Posterior reversible encephalopathy syndrome with PLEDs-plus due to mesalamine. J Neurosci Rural Pract 2014;5(1):72–5. DOI: 10.4103/0976-3147.127882.
10. Child N., Britton J. Early electroencephalogram (EEG) findings in Posterior Reversible Encephalopathy Syndrome (PRES). Neurology 2016;86(16):6.346.
11. Chou M.C., Lai P.H., Yeh L.R. et al. Posterior reversible encephalopathy syndrome: magnetic resonance imaging and diffusion-weighted imaging in 12 cases. Kaohsiung J Med Sci 2004;20(8):381–8. DOI: 10.1016/S1607-551X(09)70174-3.
12. 1Covarrubias D.J., Luetmer P.H., Campeau N.G. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol 2002;23(6):1038–48. PMID: 12063238.
13. Datar S., Singh T., Rabinstein A.A. et al. Longterm risk of seizures and epilepsy in patients with posterior reversible encephalopathy syndrome. Epilepsia 2015;56(4):564–8. DOI: 10.1111/epi.12933.
14. Grioni D., Rovelli A., Pavan F., Prunotto G. The diagnosis of posterior reversible encephalopathy syndrome. Lancet Neurol 2015;14(11):1073–74. DOI: 10.1016/S1474-4422(15)00254-9.
15. Hinchey J., Chaves C., Appignani B. et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med;334(8):494–500. DOI: 10.1056/NEJM199602223340803.
16. Kastrup O., Gerwig M., Frings M., Diener H.C. Posterior reversible encephalopathy syndrome (PRES): electroencephalographic findings and seizure patterns. J Neurol 2012;259(7):1383–9. DOI: 10.1007/s00415-011-6362-9.
17. Kozak O.S., Wijdicks E.F., Manno E.M. et al. Status epilepticus as initial manifestation of posterior reversible encephalopathy syndrome. Neurology 2007;69(9):894–7. DOI: 10.1212/01.wnl.0000269780.45472.16.
18. Lee V.H., Wijdicks E.F., Manno E.M., Rabinstein A.A. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 2008;65(2):205–10. DOI: 10.1001/archneurol.2007.46.
19. McKinney A.M., Short J., Truwit C.L. et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol 2007;189(4):904–12. DOI: 10.2214/AJR.07.2024.
20. Meierkord H., Boon P., Engelsen B. et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol 2010;17(3):348–55. DOI: 10.1111/j.1468-1331.2009.02917.x.
21. Muro V.L., Yip S., Huh L., Connolly M.B. Status epilepticus amauroticus and posterior reversible encephalopathy syndrome in children. J Clin Neurophysiol 2013;30(4):344–7. DOI: 10.1097/WNP.0b013e31829de004.
22. Natsume J., Sofue A., Yamada A., Kato K. Electroencephalographic (EEG) findings in posterior reversible encephalopathy associated with immunosuppressants. J Child Neurol 2006;21(7):620–3. DOI: 10.1177/08830738060210071201.
23. Mittal S.H., Shi vanand Pai, Rakshith K.C. et al. PRES and PLEDs: an uncommon association. EC Neurology 2015;2.2:83–6.
24. Schwartz R.B., Bravo S.M., Klufas R.A. et al. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am J Roentgenol 1995;165(3):627–31. DOI: 10.2214/ajr.165.3.7645483.
25. Sha Z., Moran B.P., McKinney A.M. 4th, Henry T.R. Seizure outcomes of posterior reversible encephalopathy syndrome and correlations with electroencephalographic changes. Epilepsy Behav 2015;48:70–4. DOI: 10.1016/j.yebeh.2015.05.027.
26. Skiba V., Etienne M., Miller J.A. Development of chronic epilepsy after recurrent episodes of posterior reversible encephalopathy syndrome associated with periodic lateralized epileptiform discharges. Seizure 2011;20(1):93–5. DOI: 10.1016/j.seizure.2010.10.005.
Review
For citations:
Bobylova M.Yu., Zakharova A.Yu., Khomyakova S.P. ELECTROENCEPHALOGRAPHIC CHANGES AND PROGNOSIS FOR THE DEVELOPMENT OF EPILEPSY IN PATIENTS WITH POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES): LITERATURE REVIEW. Russian Journal of Child Neurology. 2017;12(2):43-51. (In Russ.) https://doi.org/10.17650/2073-8803-2017-12-2-43-51
Views:
1609
Email this article 